Abstract
When a cancer type proves to be radioresistant to treatment with X-rays, the use of neutrons may constitute therapeutic gain provided the cells are relatively sensitive to high-LET radiation. In this work studies with different tumor cell types are reported following exposure to either photons or different neutron energies used in clinical radiation therapy. Potential for therapeutic gain is clearly noted for neutrons with a mean energy of 6 MeV whilst that for 29 MeV neutrons is dependent on the cell types used in the study.
Publisher
Trans Tech Publications, Ltd.
Reference32 articles.
1. A. Wambersie, G.W. Barendsen, N. Breteau, Overview and prospects of the application of fast neutrons in cancer therapy, J Eur Radiother 5 (1984) 248-264.
2. J.J. Battermann, K. Breur, G.A. M Hart, Observations on pulmonary metastases in patients after single doses and multiple fractions of fast neutrons and cobalt-60 gamma rays, Eur J Cancer. 17 (1981) 539-548.
3. G. Schmitt, A. Wambersie, Review of the clinical results of fast neutron therapy, Radiother Onkol 17 (1990) 47-57.
4. E.J. Hall, Radiobiological intercomparisons in vivo and in vitro, Int J Radiat Oncol Biol Phys. 3 (1977) 195-201.
5. G.E. Laramore, J.T. Griffith, M. Boespflug, Fast neutron radiotherapy for sarcomas of soft tissue, bone and cartilage, Am J Clin Oncol. 12 (1989) 320 –326.